Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology - O'Brien_2016_J.Psychopharmacol_31_147 |
| Author(s) : O'Brien JT , Holmes C , Jones M , Jones R , Livingston G , McKeith I , Mittler P , Passmore P , Ritchie C , Robinson L , Sampson EL , Taylor JP , Thomas A , Burns A |
| Ref : J Psychopharmacol , 31 :147 , 2016 |
| Abstract : O'Brien_2016_J.Psychopharmacol_31_147 |
| ESTHER : O'Brien_2016_J.Psychopharmacol_31_147 |
| PubMedSearch : O'Brien_2016_J.Psychopharmacol_31_147 |
| PubMedID: 28103749 |
| Title : Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study - Walker_2012_BMJ.Open_2_e000380 |
| Author(s) : Walker Z , McKeith I , Rodda J , Qassem T , Tatsch K , Booij J , Darcourt J , O'Brien J |
| Ref : BMJ Open , 2 :e000380 , 2012 |
| Abstract : Walker_2012_BMJ.Open_2_e000380 |
| ESTHER : Walker_2012_BMJ.Open_2_e000380 |
| PubMedSearch : Walker_2012_BMJ.Open_2_e000380 |
| PubMedID: 22318660 |
| Title : Donepezil and memantine for moderate-to-severe Alzheimer's disease - Howard_2012_N.Engl.J.Med_366_893 |
| Author(s) : Howard R , McShane R , Lindesay J , Ritchie C , Baldwin A , Barber R , Burns A , Dening T , Findlay D , Holmes C , Hughes A , Jacoby R , Jones R , McKeith I , Macharouthu A , O'Brien J , Passmore P , Sheehan B , Juszczak E , Katona C , Hills R , Knapp M , Ballard C , Brown R , Banerjee S , Onions C , Griffin M , Adams J , Gray R , Johnson T , Bentham P , Phillips P |
| Ref : N Engl J Med , 366 :893 , 2012 |
| Abstract : Howard_2012_N.Engl.J.Med_366_893 |
| ESTHER : Howard_2012_N.Engl.J.Med_366_893 |
| PubMedSearch : Howard_2012_N.Engl.J.Med_366_893 |
| PubMedID: 22397651 |
| Title : Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance - Matthews_2010_Int.J.Geriatr.Psychiatry_25_719 |
| Author(s) : Matthews FE , Muniz-Terrera G , McKeith I , Brayne C |
| Ref : Int J Geriatr Psychiatry , 25 :719 , 2010 |
| Abstract : Matthews_2010_Int.J.Geriatr.Psychiatry_25_719 |
| ESTHER : Matthews_2010_Int.J.Geriatr.Psychiatry_25_719 |
| PubMedSearch : Matthews_2010_Int.J.Geriatr.Psychiatry_25_719 |
| PubMedID: 19946863 |
| Title : DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT - Jones_2009_Trials_10_57 |
| Author(s) : Jones R , Sheehan B , Phillips P , Juszczak E , Adams J , Baldwin A , Ballard C , Banerjee S , Barber B , Bentham P , Brown R , Burns A , Dening T , Findlay D , Gray R , Griffin M , Holmes C , Hughes A , Jacoby R , Johnson T , Knapp M , Lindesay J , McKeith I , McShane R , Macharouthu A , O'Brien J , Onions C , Passmore P , Raftery J , Ritchie C , Howard R |
| Ref : Trials , 10 :57 , 2009 |
| Abstract : Jones_2009_Trials_10_57 |
| ESTHER : Jones_2009_Trials_10_57 |
| PubMedSearch : Jones_2009_Trials_10_57 |
| PubMedID: 19630974 |
| Title : Reaching the population with dementia drugs: what are the challenges? - Matthews_2007_Int.J.Geriatr.Psychiatry_22_627 |
| Author(s) : Matthews FE , McKeith I , Bond J , Brayne C |
| Ref : Int J Geriatr Psychiatry , 22 :627 , 2007 |
| Abstract : Matthews_2007_Int.J.Geriatr.Psychiatry_22_627 |
| ESTHER : Matthews_2007_Int.J.Geriatr.Psychiatry_22_627 |
| PubMedSearch : Matthews_2007_Int.J.Geriatr.Psychiatry_22_627 |
| PubMedID: 17136710 |
| Title : Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis - Bhasin_2007_Int.J.Geriatr.Psychiatry_22_890 |
| Author(s) : Bhasin M , Rowan E , Edwards K , McKeith I |
| Ref : Int J Geriatr Psychiatry , 22 :890 , 2007 |
| Abstract : Bhasin_2007_Int.J.Geriatr.Psychiatry_22_890 |
| ESTHER : Bhasin_2007_Int.J.Geriatr.Psychiatry_22_890 |
| PubMedSearch : Bhasin_2007_Int.J.Geriatr.Psychiatry_22_890 |
| PubMedID: 17265415 |
| Title : Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease - Burn_2006_Mov.Disord_21_1899 |
| Author(s) : Burn D , Emre M , McKeith I , De Deyn PP , Aarsland D , Hsu C , Lane R |
| Ref : Movement Disordersord , 21 :1899 , 2006 |
| Abstract : Burn_2006_Mov.Disord_21_1899 |
| ESTHER : Burn_2006_Mov.Disord_21_1899 |
| PubMedSearch : Burn_2006_Mov.Disord_21_1899 |
| PubMedID: 16960863 |
| Title : Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology - Burns_2006_J.Psychopharmacol_20_732 |
| Author(s) : Burns A , O'Brien J , Auriacombe S , Ballard C , Broich K , Bullock R , Feldman H , Ford G , Knapp M , McCaddon A , Iliffe S , Jacova C , Jones R , Lennon S , McKeith I , Orgogozo JM , Purandare N , Richardson M , Ritchie C , Thomas A , Warner J , Wilcock G , Wilkinson D |
| Ref : J Psychopharmacol , 20 :732 , 2006 |
| Abstract : Burns_2006_J.Psychopharmacol_20_732 |
| ESTHER : Burns_2006_J.Psychopharmacol_20_732 |
| PubMedSearch : Burns_2006_J.Psychopharmacol_20_732 |
| PubMedID: 17060346 |
| Title : The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients - Ballard_2005_Dement.Geriatr.Cogn.Disord_19_357 |
| Author(s) : Ballard C , Morris C , Kalaria R , McKeith I , Perry R , Perry E |
| Ref : Dementia & Geriatric Cognitive Disorders , 19 :357 , 2005 |
| Abstract : Ballard_2005_Dement.Geriatr.Cogn.Disord_19_357 |
| ESTHER : Ballard_2005_Dement.Geriatr.Cogn.Disord_19_357 |
| PubMedSearch : Ballard_2005_Dement.Geriatr.Cogn.Disord_19_357 |
| PubMedID: 15802910 |
| Title : Dementia with Lewy bodies - McKeith_2004_Lancet.Neurol_3_19 |
| Author(s) : McKeith I , Mintzer J , Aarsland D , Burn D , Chiu H , Cohen-Mansfield J , Dickson D , Dubois B , Duda JE , Feldman H , Gauthier S , Halliday G , Lawlor B , Lippa C , Lopez OL , Carlos Machado J , O'Brien J , Playfer J , Reid W |
| Ref : Lancet Neurol , 3 :19 , 2004 |
| Abstract : McKeith_2004_Lancet.Neurol_3_19 |
| ESTHER : McKeith_2004_Lancet.Neurol_3_19 |
| PubMedSearch : McKeith_2004_Lancet.Neurol_3_19 |
| PubMedID: 14693108 |
| Title : Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies - Perry_2003_Neurology_60_1852 |
| Author(s) : Perry E , McKeith I , Ballard C |
| Ref : Neurology , 60 :1852 , 2003 |
| Abstract : Perry_2003_Neurology_60_1852 |
| ESTHER : Perry_2003_Neurology_60_1852 |
| PubMedSearch : Perry_2003_Neurology_60_1852 |
| PubMedID: 12796550 |
| Title : Delusions associated with elevated muscarinic binding in dementia with Lewy bodies - Ballard_2000_Ann.Neurol_48_868 |
| Author(s) : Ballard C , Piggott M , Johnson M , Cairns N , Perry R , McKeith I , Jaros E , O'Brien J , Holmes C , Perry E |
| Ref : Annals of Neurology , 48 :868 , 2000 |
| Abstract : Ballard_2000_Ann.Neurol_48_868 |
| ESTHER : Ballard_2000_Ann.Neurol_48_868 |
| PubMedSearch : Ballard_2000_Ann.Neurol_48_868 |
| PubMedID: 11117543 |
| Title : Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases - Perry_2000_Eur.J.Pharmacol_393_215 |
| Author(s) : Perry E , Martin-Ruiz C , Lee M , Griffiths M , Johnson M , Piggott M , Haroutunian V , Buxbaum JD , Nasland J , Davis K , Gotti C , Clementi F , Tzartos SJ , Cohen O , Soreq H , Jaros E , Perry R , Ballard C , McKeith I , Court J |
| Ref : European Journal of Pharmacology , 393 :215 , 2000 |
| Abstract : Perry_2000_Eur.J.Pharmacol_393_215 |
| ESTHER : Perry_2000_Eur.J.Pharmacol_393_215 |
| PubMedSearch : Perry_2000_Eur.J.Pharmacol_393_215 |
| PubMedID: 10771016 |
| Title : Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study - McKeith_2000_Lancet_356_2031 |
| Author(s) : McKeith I , Del Ser T , Spano P , Emre M , Wesnes K , Anand R , Cicin-Sain A , Ferrara R , Spiegel R |
| Ref : Lancet , 356 :2031 , 2000 |
| Abstract : McKeith_2000_Lancet_356_2031 |
| ESTHER : McKeith_2000_Lancet_356_2031 |
| PubMedSearch : McKeith_2000_Lancet_356_2031 |
| PubMedID: 11145488 |
| Title : The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial - Shikiar_2000_J.Am.Geriatr.Soc_48_268 |
| Author(s) : Shikiar R , Shakespeare A , Sagnier PP , Wilkinson D , McKeith I , Dartigues JF , Dubois B |
| Ref : J Am Geriatr Soc , 48 :268 , 2000 |
| Abstract : Shikiar_2000_J.Am.Geriatr.Soc_48_268 |
| ESTHER : Shikiar_2000_J.Am.Geriatr.Soc_48_268 |
| PubMedSearch : Shikiar_2000_J.Am.Geriatr.Soc_48_268 |
| PubMedID: 10733052 |
| Title : A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study - Dubois_1999_Int.J.Geriatr.Psychiatry_14_973 |
| Author(s) : Dubois B , McKeith I , Orgogozo JM , Collins O , Meulien D |
| Ref : Int J Geriatr Psychiatry , 14 :973 , 1999 |
| Abstract : Dubois_1999_Int.J.Geriatr.Psychiatry_14_973 |
| ESTHER : Dubois_1999_Int.J.Geriatr.Psychiatry_14_973 |
| PubMedSearch : Dubois_1999_Int.J.Geriatr.Psychiatry_14_973 |
| PubMedID: 10556869 |